Condition
Primary Lung Cancer
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting1
Not Yet Recruiting1
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05150210Not ApplicableActive Not RecruitingPrimary
SP Thoracic IDE Study
NCT07076914Phase 2Not Yet RecruitingPrimary
Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy
NCT06775821Recruiting
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
NCT01830426CompletedPrimary
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Showing all 4 trials